CTTC News: > New Pain Therapy Treatment Keeps Pilot Aloft

New Post Public Reply Private Reply Replies (0) Message Board
tryz
CTTC News : > New Pain Therapy Treatment Keeps Pilot Aloft
Tuesday, May 5, 2015

In March, financial advisor Dale Terwedo, 55, owner of TFS Advisors, LLC, of Edmonds, celebrated a milestone—five years cancer free. These days his risk of getting colon cancer is the same as anyone else’s.

Dale beat cancer, but there was a price. A chemotherapy drug left him with lingering, painful neuropathy in his feet and legs. Imagine the pins and needles when your foot falls asleep. Then imagine those pins and needles are burning. Imagine your feet at the end of a long hike in too small boots. “It’s like walking on exposed aggregate concrete in summer,” Dale said.

He takes a hefty dose of B vitamins to try to ease the pain and he could take medication for relief— but he won’t. “If I did, I couldn’t fly,” he said. Dale is a pilot. It’s one of his joys and it’s a way to give back. He’s an Angel Flight pilot, providing free transportation for people who need medical care. “I’ve always been an active adventurer. I try new things, see new places.”

So, when Dale’s oncologist told him about a new treatment that might cure the pain but didn’t involve drugs, he jumped on it. “I didn’t expect insurance to cover it, but I didn’t care,” he said. The Calmare® Pain Therapy Treatment uses disposable electrodes at the area of greatest pain to transmit a “no-pain” message to the nerves. It requires several daily treatments, but is painless.

“Our new Calmare® treatment is the most effective measure that I have seen in over 30 years of treating cancer patients,” said Dr. James Congdon, an oncologist with The Everett Clinic. “This non-invasive procedure has often been able to reverse painful and debilitating neuropathy symptoms and return people to pain free, productive lives. It has proven effective even for patients whose symptoms have not responded to other standard treatments.”


For some people, the pain recedes, even goes away, after a treatment or two. That wasn’t Dale’s experience but, after several treatments (12 in all), he did notice a difference. “I experienced about a 70 percent reduction of the acute pain. There’s still some numbness and stiffness,” he said. But it’s better. He can fly. He can get a good workout at his racquetball game two days a week, along with other workouts. He can put his feet under the sheets again. And, although he was prepared to pay for the treatment out of pocket, his insurance did come through.

He plans to get a booster round of treatments soon. “It was worth it. It helped,” he said.

Ask your oncologist about Calmare® for the treatment of the following issues:

Chemotherapy-induced peripheral neuropathy (CIPN)
Phantom limb syndrome
Sciatica
Post-surgical neuropathic pain
Low back pain
Neck pain
Reflex sympathetic dystrophy
Postherpetic neuralgia (PHN)


- See more at: http://www.everettclinic.com/news/new-pain-th...BJZKA.dpuf

Calmare Therapeutics, Inc (CTTC) Stock Research Links

CTTC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Key Insights for Snap Inc. Investors Amid Lawsuit Deadline

Updated Category News Views 172

Important Notice for Snap Investors Investors holding shares of Snap, Inc. have an important deadline approaching as the firm faces a class action lawsuit. If you have purchased or acquired Snap securities between specific dates, it’s crucial to understand your legal rights. The law firm Bragar Eagel & Squire, P.C. is encouraging affected investors to reach out for more...

Continue Reading
Data Security Concerns: Rockland Trust Customers Affected

Updated Category News Views 96

Understanding Edelson Lechtzin LLP's Investigation into the Data Breach Recently, the law firm Edelson Lechtzin LLP has stepped up to investigate claims from customers of Rockland Trust Company following a serious data breach. Reports have surfaced indicating that a third-party vendor accidentally revealed sensitive personal information. This alarming news has...

Continue Reading
Surging Growth Predicted for the Sex Toys Market by 2029

Updated Category News Views 117

The Future of the Sex Toys Market: A Transformative Growth Journey The sex toys market is on the cusp of a significant evolution, projected to expand by USD 34.54 billion from 2025 to 2029. Various factors are fueling this growth, including widespread acceptance, technological advancements, and changing consumer attitudes towards sexual wellness and pleasure. While the...

Continue Reading
Alvotech S.A. Reaches Significant Shareholding Milestone

Updated Category News Views 187

Alvotech S.A. Announces Shareholding Update Alvotech S.A. has recently reported a noteworthy development regarding its shareholding structure. It has been confirmed that as of a specific date, Alvotech now holds 6.73% of its own shares, which is a significant crossing above the 5% threshold. This milestone reflects the company’s strategic approach to managing its...

Continue Reading
Exciting Details About Donatella Boutique Hotel's Launch

Updated Category News Views 297

Anticipation Grows for Donatella Boutique Hotel & Restaurant Excitement is in the air as the Donatella Boutique Hotel & Restaurant prepares to make its grand debut. This exquisite hotel aims to redefine luxury accommodation with a focus on Mediterranean elegance. While similar names may have led to confusion, it is important to clarify that there is no affiliation with...

Continue Reading